Vitamin E claim
This article was originally published in The Tan Sheet
Executive Summary
Proposed vitamin E/heart disease dietary supplement health claim rejected by FDA Feb. 9. Plaintiffs in Whitaker v. Shalala lawsuit pending in D.C. federal court are now expected to restart the litigation, which has been stayed pending agency's reexamination of the claim
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning